Upgrade to SI Premium - Free Trial

Amphastar Pharma (AMPH)

23.18 -0.66 (2.77%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Barclays August 19, 2026 3:21 AM - StreetInsider Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F. August 18, 2026 5:57 PM - SEC Filing Form 4 Amphastar Pharmaceutical For: Aug 11 Filed by: PRINS RICHARD K August 12, 2026 6:15 PM - SEC Filing Form 4 Amphastar Pharmaceutical For: Aug 07 Filed by: PETERS WILLIAM J August 11, 2026 4:57 PM - SEC Filing Form 144 Amphastar Pharmaceutical Filed by: PRINS RICHARD K August 11, 2026 11:54 AM - SEC Filing Form 144 Amphastar Pharmaceutical Filed by: PETERS WILLIAM J August 7, 2026 4:11 PM - SEC Filing Amphastar Pharmaceuticals (AMPH) PT Raised to $20 at Wells Fargo August 7, 2026 8:20 AM - StreetInsider Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Piper Sandler August 7, 2026 7:48 AM - StreetInsider Amphastar Pharma (AMPH) Tops Q2 EPS by 28c August 7, 2026 2:31 AM - StreetInsider Form 10-Q Amphastar Pharmaceutical For: Jun 30 August 6, 2026 4:51 PM - SEC Filing Form 8-K Amphastar Pharmaceutical For: Aug 06 August 6, 2026 4:37 PM - SEC Filing Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026 August 6, 2026 4:05 PM - PR NewsWire Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 July 29, 2026 6:00 AM - PR NewsWire Form SCHEDULE 13G Amphastar Pharmaceutical Filed by: DIMENSIONAL FUND ADVISORS LP July 14, 2026 1:27 PM - SEC Filing Form 4 Amphastar Pharmaceutical For: Jul 09 Filed by: Pierce Anthony T July 13, 2026 7:38 PM - SEC Filing Form 3 Amphastar Pharmaceutical For: Jul 09 Filed by: Pierce Anthony T July 13, 2026 7:36 PM - SEC Filing Form 8-K Amphastar Pharmaceutical For: Jul 09 July 13, 2026 6:03 AM - SEC Filing FDA issues warning letter to Amphastar Pharma subsidiary over manufacturing July 8, 2026 6:04 AM - StreetInsider Form 8-K Amphastar Pharmaceutical For: Jul 02 July 8, 2026 6:02 AM - SEC Filing BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns June 29, 2026 11:51 AM - StreetInsider BofA Securities Downgrades Amphastar Pharmaceuticals (AMPH) to Underperform June 29, 2026 6:10 AM - StreetInsider FDA approves second OTC naloxone nasal spray, Rextovy June 16, 2026 10:08 AM - StreetInsider Full Article List